Skip to content
value.today

LumaCyte, Inc.

Formerly Lumacye, LLC

Total raised
$17 M
2 rounds on record
Latest round
$10 M
Aug 2023
First round on record
Feb 2022
Today
Private
No later event on record

Funding rounds

2 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of LumaCyte, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Aug 2023$10 MNo. 2$10 to $50 million

LumaCyte, Inc.: Raise no. 2, Aug 2023

Investors in this round

1 investor had bought by the notice of Sep 14, 2023: 1 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$10 M of $13 M offered; $3 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, other: Equity to be issued upon conversion of previously issued convertible securities
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
$600,000
Finders' fees
none
Paid to its own people
$2,819,742 (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks sales commissions and payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Renee Hart · Executive Officer, Director
  • Sean Hart · Executive Officer, Director
  • Dennis Walczewski · Director
  • Paul Meister · Director
  • Robert Heiser · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • EuroConsult Capital LLC (CRD 143366) · London, United KingdomSold in MA

Remarks in the notice

  • On the use of proceeds: “Additional funds may be used to redeem shares from related parties in an estimated amount of up to the amount above. In addition, gross proceeds may be applied to employment compensation for related parties.”

Signed by Sean Hart, Chief Executive Officer. Source: SEC Form D, newest notice filed Sep 14, 2023. Read the notice at the SEC.

equitySEC
Feb 2022$7 MNo. 1$2 to $10 million

LumaCyte, Inc.: Raise no. 1, Feb 2022

Investors in this round

3 investors had bought by the notice of Mar 2, 2022: 3 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$7 M of $9 M offered; $3 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
$5 million to $25 million
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Renee Hart · Executive Officer, Director
  • Sean Hart · Executive Officer, Director
  • Dennis Walczewski · Director
  • Paul Meister · Director
  • Pete Buzy · Director
  • Robert Heiser · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “The total amount sold includes equity issued upon the conversion of outstanding notes.”
  • On the use of proceeds: “Payments to officers and directors are estimated to be made out of the company's revenues, not proceeds of the offering.”

Signed by Sean Hart, Chief Executive Officer. Source: SEC Form D, newest notice filed Mar 2, 2022. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • LumaCyte, Inc. chose not to state its revenue in its newest notice of a funding round (Sep 2023).

    SEC Form D · Sep 2023

  • The industry group it chose in its notices: Biotechnology.

    SEC Form D · Sep 2023

That is all the official record says: LumaCyte, Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of LumaCyte, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 2 rounds above had up to 3 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by LumaCyte, Inc.
NameRoleNamed in
Renee HartExecutive officerSep 2023
Sean HartExecutive officerSep 2023
Dennis WalczewskiDirectorSep 2023
Paul MeisterDirectorSep 2023
Renee HartDirectorSep 2023
Robert HeiserDirectorSep 2023
Sean HartDirectorSep 2023
Pete BuzyDirectorMar 2022